Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Universe Pharmaceuticals stock | $2.29
Learn how to easily invest in Universe Pharmaceuticals stock.
Universe Pharmaceuticals INC is a biotechnology business based in the US. Universe Pharmaceuticals shares (UPC) are listed on the NASDAQ and all prices are listed in US Dollars.
How to buy shares in Universe Pharmaceuticals
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – UPC – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Universe Pharmaceuticals stock price (NASDAQ: UPC)Use our graph to track the performance of UPC stocks over time.
Universe Pharmaceuticals shares at a glance
|Latest market close||$2.29|
|52-week range||$2.23 - $7.22|
|50-day moving average||$2.37|
|200-day moving average||$2.84|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.60|
Buy Universe Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Universe Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Universe Pharmaceuticals price performance over time
|1 week (2021-10-21)||-2.14%|
|1 month (2021-09-28)||-11.58%|
|3 months (2021-07-28)||-4.58%|
|6 months (2021-04-28)||-38.93%|
|1 year (2020-10-24)||N/A|
|2 years (2019-10-24)||N/A|
|3 years (2018-10-24)||N/A|
|5 years (2016-10-24)||N/A|
Is Universe Pharmaceuticals under- or over-valued?
Valuing Universe Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Universe Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Universe Pharmaceuticals's P/E ratio
Universe Pharmaceuticals's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 4x. In other words, Universe Pharmaceuticals shares trade at around 4x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
However, Universe Pharmaceuticals's P/E ratio is best considered in relation to those of others within the biotechnology industry or those of similar companies.
Universe Pharmaceuticals's EBITDA
Universe Pharmaceuticals's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $13.7 million.
The EBITDA is a measure of a Universe Pharmaceuticals's overall financial performance and is widely used to measure a its profitability.
To put Universe Pharmaceuticals's EBITDA into context you can compare it against that of similar companies.
Universe Pharmaceuticals financials
|Revenue TTM||$38.6 million|
|Operating margin TTM||34.33%|
|Gross profit TTM||$14.1 million|
|Return on assets TTM||17.61%|
|Return on equity TTM||28.26%|
|Market capitalisation||$50.8 million|
TTM: trailing 12 months
Shorting Universe Pharmaceuticals shares
There are currently 38,756 Universe Pharmaceuticals shares held short by investors – that's known as Universe Pharmaceuticals's "short interest". This figure is 52.1% down from 80,958 last month.
There are a few different ways that this level of interest in shorting Universe Pharmaceuticals shares can be evaluated.
Universe Pharmaceuticals's "short interest ratio" (SIR)
Universe Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Universe Pharmaceuticals shares currently shorted divided by the average quantity of Universe Pharmaceuticals shares traded daily (recently around 143540.74074074). Universe Pharmaceuticals's SIR currently stands at 0.27. In other words for every 100,000 Universe Pharmaceuticals shares traded daily on the market, roughly 270 shares are currently held short.
To gain some more context, you can compare Universe Pharmaceuticals's short interest ratio against those of similar companies.
However Universe Pharmaceuticals's short interest can also be evaluated against the total number of Universe Pharmaceuticals shares, or, against the total number of tradable Universe Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Universe Pharmaceuticals's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Universe Pharmaceuticals shares in existence, roughly 0 shares are currently held short) or 0.0042% of the tradable shares (for every 100,000 tradable Universe Pharmaceuticals shares, roughly 4 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Universe Pharmaceuticals.
Find out more about how you can short Universe Pharmaceuticals stock.
Universe Pharmaceuticals share dividends
We're not expecting Universe Pharmaceuticals to pay a dividend over the next 12 months.
Universe Pharmaceuticals overview
Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief for common chronic health conditions in the elderly for the physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Ji'an, China. Universe Pharmaceuticals INC operates as a subsidiary of Sununion Holding Group Limited. .
Universe Pharmaceuticals in the news
Frequently asked questionsWhat percentage of Universe Pharmaceuticals is owned by insiders or institutions?
Currently 67.457% of Universe Pharmaceuticals shares are held by insiders and 0.229% by institutions. When does the fiscal year end for Universe Pharmaceuticals?
Universe Pharmaceuticals's fiscal year ends in September. Where is Universe Pharmaceuticals based?
Universe Pharmaceuticals's address is: No. 265, Jingjiu Avenue, Ji'an, China What is Universe Pharmaceuticals's ISIN number?
Universe Pharmaceuticals's international securities identification number is: KYG9442G1047
More guides on Finder
How and where to buy NFTs
Read our comprehensive look at NFTs, including what they are, how to invest and the risks attached with buying them.
Today’s top US stocks: Cleveland-Cliffs (CLF ↑11.1%), Suzano ADRs (SUZ ↑7.0%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq on Oct. 22, 2021
How to buy Trump Media and Technology Group (TMTG) stock when it goes public
Everything we know about the Trump Media and Technology Group IPO, plus information on how to buy in.
How to buy Valkyrie Bitcoin Strategy ETF (BTF)
Steps to owning and managing Valkyrie Bitcoin Strategy ETF units.
Today’s top US stocks: KE Holdings ADRs (BEKE ↑9.1%), Futu Holdings ADRs (FUTU ↑7.8%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq on Oct. 21, 2021
How to buy ProShares Bitcoin Strategy ETF (BITO)
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
How to buy The Real Good Food Company (RGF) stock when it goes public
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
How to buy Lulu’s Fashion Lounge Holdings (LVLU) stock when it goes public
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
How to buy Allarity Therapeutics (ALLR) stock when it goes public
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
How to buy Jupiter Neurosciences (JUNS) stock when it goes public
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Ask an Expert